IS6559A - Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum - Google Patents

Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum

Info

Publication number
IS6559A
IS6559A IS6559A IS6559A IS6559A IS 6559 A IS6559 A IS 6559A IS 6559 A IS6559 A IS 6559A IS 6559 A IS6559 A IS 6559A IS 6559 A IS6559 A IS 6559A
Authority
IS
Iceland
Prior art keywords
mammals
treat
prevent bacterial
azalide antibiotic
antibiotic formulations
Prior art date
Application number
IS6559A
Other languages
English (en)
Inventor
Alan Boettner Wayne
Connor Canning Peter
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS6559A publication Critical patent/IS6559A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IS6559A 2000-04-27 2002-09-20 Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum IS6559A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27
PCT/IB2001/000519 WO2001081358A1 (en) 2000-04-27 2001-03-26 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals

Publications (1)

Publication Number Publication Date
IS6559A true IS6559A (is) 2002-09-20

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6559A IS6559A (is) 2000-04-27 2002-09-20 Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum

Country Status (30)

Country Link
US (2) US20020019353A1 (is)
EP (1) EP1276747A1 (is)
JP (1) JP2004516233A (is)
KR (1) KR20030031479A (is)
CN (1) CN1227258C (is)
AP (1) AP2002002652A0 (is)
AR (1) AR028041A1 (is)
AU (1) AU4269301A (is)
BG (1) BG107168A (is)
BR (1) BR0110382A (is)
CA (1) CA2407448A1 (is)
CZ (1) CZ20023409A3 (is)
EA (1) EA200200995A1 (is)
GT (1) GT200100063A (is)
HU (1) HUP0300585A3 (is)
IL (1) IL152421A0 (is)
IS (1) IS6559A (is)
MA (1) MA26896A1 (is)
MX (1) MXPA02010586A (is)
NO (1) NO20025134L (is)
OA (1) OA12257A (is)
PA (1) PA8515601A1 (is)
PE (1) PE20011188A1 (is)
PL (1) PL359861A1 (is)
SK (1) SK14882002A3 (is)
TN (1) TNSN01063A1 (is)
UY (1) UY26678A1 (is)
WO (1) WO2001081358A1 (is)
YU (1) YU78702A (is)
ZA (1) ZA200208603B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
WO2003011266A2 (en) * 2001-08-01 2003-02-13 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
US8314071B2 (en) 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
CA2828635C (en) * 2011-03-04 2020-01-14 Grunenthal Gmbh Parenteral administration of tapentadol
CA2877884C (en) * 2012-06-27 2022-09-06 Kemin Industries, Inc. Animal feed compositions for controlling coccidiosis in animals
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
EP3554254B1 (en) 2016-12-15 2025-05-07 Société des Produits Nestlé S.A. Compositions and methods that modulate bacteria in a companion animal
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
US11059845B2 (en) * 2017-02-22 2021-07-13 ISR Immune System Regulation Holding AB (publ) Immune stimulating macrolides
AU2019385333B2 (en) * 2018-11-19 2025-04-17 President And Fellows Of Harvard College C10-alkylene substituted 13-membered macrolides and uses thereof
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
CN115461352A (zh) 2020-03-12 2022-12-09 硕腾服务有限责任公司 免疫调节脲氮杂内酯类
KR20240056746A (ko) 2021-09-07 2024-04-30 조에티스 서비시즈 엘엘씨 면역조정성 아잘라이드

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
HUP0300585A3 (en) 2003-09-29
PE20011188A1 (es) 2001-11-24
BG107168A (bg) 2003-07-31
EA200200995A1 (ru) 2003-04-24
AR028041A1 (es) 2003-04-23
GT200100063A (es) 2002-02-18
NO20025134D0 (no) 2002-10-25
IL152421A0 (en) 2003-05-29
CA2407448A1 (en) 2001-11-01
SK14882002A3 (en) 2004-11-03
MA26896A1 (fr) 2004-12-20
US20040235759A1 (en) 2004-11-25
EP1276747A1 (en) 2003-01-22
NO20025134L (no) 2002-12-19
PL359861A1 (en) 2004-09-06
HUP0300585A2 (hu) 2003-06-28
CN1227258C (zh) 2005-11-16
MXPA02010586A (es) 2003-03-10
TNSN01063A1 (fr) 2005-11-10
US20020019353A1 (en) 2002-02-14
YU78702A (sh) 2005-11-28
BR0110382A (pt) 2003-06-24
ZA200208603B (en) 2003-10-24
UY26678A1 (es) 2001-12-28
PA8515601A1 (es) 2002-07-30
OA12257A (en) 2003-11-06
CN1429232A (zh) 2003-07-09
AU4269301A (en) 2001-11-07
KR20030031479A (ko) 2003-04-21
AP2002002652A0 (en) 2002-12-31
WO2001081358A1 (en) 2001-11-01
JP2004516233A (ja) 2004-06-03
CZ20023409A3 (cs) 2004-01-14

Similar Documents

Publication Publication Date Title
IS6559A (is) Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum
ITRM980103A0 (it) Uso di batteri dotati di arginina deiminasi per introdurre apostosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
ATE277063T1 (de) 6-o-alkylerythromycinoxim b
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
AP2003002906A0 (en) Crystal forms of azithromycin
IS6177A (is) Samsetning af mjólkursýrugerlum og notkun hennar til að fyrirbyggja og/eða meðhöndla sýkingar og bólguástand
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
IL148641A0 (en) Topical treatment of streptococcal infections
DE60003586D1 (de) Antibiotische azalid-zusammensetzungen
BR0116216A (pt) Inibidores de girase e seus usos
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
ATE345350T1 (de) Makrolidantibiotika
MY137020A (en) Diazabicyclic central nervous system active agents
BR9909994A (pt) Quinolinas usadas como inibidores de mrs e bactericidas
PT1200065E (pt) Composicao de ovulos intravaginais de clindamicina
BR0010220A (pt) Compostos de pirimidinona
DE60042401D1 (de) Fab-i inhibitoren
PT1274407E (pt) Utilizacao de agonistas de ppar-gama em doencas induzidas por netrofilos
DK1131331T3 (da) 13-leddede azalider og deres anvendelse som antibiotiske midler
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2002364964A8 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
DE60142521D1 (de) Aerobes fermentationsverfahren
DE60139712D1 (de) Ionophore antibiotische formulierungen
IS6618A (is) Hýgrómýsín A afleiður til meðhöndlunar á bakteríu- og frumdýrasýkingum
EP1333914A4 (en) TENSIDE SYSTEM FOR IMPROVING THE PRODUCTION OF GEL-SHAPED AIR IMPROVERS